skip navigation nih record
Vol. LXII, No. 23
November 12, 2010
cover

previous story

next story


Milestones

NCIís Adhya Elected to Hungarian Academy
Dr. Sankar Adhya
Dr. Sankar Adhya, senior investigator and chief of the developmental genetics section, Laboratory of Molecular Biology, NCI, was recently elected as a foreign member to the Hungarian Academy of Sciences. He received the honor for his contributions to the role of DNA structure in gene regulation. The Hungarian Academy elects its members every 3 years.

NCIís Potter Honored
Dr. Michael Potter (c), a pioneer in the study of chromosomal translocations. Also on hand were George Klein (l) of the Karolinska Institute and Robert Kyle of the Mayo Clinic.

The National Cancer Institute and the NIH Office of Rare Diseases Research recently sponsored a meeting on the Etiology of Chromosomal Translocations. The conference brought together scientists studying the molecular details and pathogenesis of chromosomal translocations and honored Dr. Michael Potter (c), a pioneer in the study of chromosomal translocations. Also on hand were George Klein (l) of the Karolinska Institute and Robert Kyle of the Mayo Clinic.


NIDCD Council Adds Five Members
NIDCD director Dr. James Battey (c) welcomes new council members (from l) Drs. Gerald Berke, Lauren Bakaletz, Saumil Merchant and Bevan Yueh. Dr. Carolyn Stern is not shown.

NIDCD director Dr. James Battey (c) welcomes new council members (from l) Drs. Gerald Berke, Lauren Bakaletz, Saumil Merchant and Bevan Yueh. Dr. Carolyn Stern is not shown.

The National Deafness and Other Communication Disorders Advisory Council welcomed five new members at its recent meeting. The meeting included a presentation by NIH director Dr. Francis Collins, who described NIH research highlights and areas of emphasis and answered questions from council members. The new members are:

Dr. Lauren Bakaletz, professor in the department of otolaryngology, Ohio State University, and vice-president for basic science research at the Research Institute at Nationwide Childrenís Hospital, Columbus, Ohio. Her work includes understanding the pathogenic mechanisms operating in otitis media, particularly the roles of bacterial adhesives and biofilm formation.

Dr. Gerald Berke, chief of head and neck surgery in the school of medicine at the University of California at Los Angeles. His scientific work includes voice disorders, swallowing problems, snoring, deviated or perforated septa, parathyroid and thyroid disease and trauma.

Dr. Saumil Merchant, the Gudrun Larsen Eliasen and Nels Kristian Eliasen chair in otology and laryngology at Harvard Medical School. His research interests include pathology of the middle ear to better understand sound transmission through normal, diseased and reconstructed middle ears.

Dr. Carolyn Stern, a family physician and partner of DeafDoc.org, a web site that covers health care issues using American Sign Language and captions. She also works as an urgent care physician in the Unity Health System and is medical director at Rochester School for the Deaf.

Dr. Bevan Yueh, professor and chair of the department of otolaryngology/head and neck surgery at the University of Minnesota. His scientific interests include head and neck surgery, clinical epidemiology, head and neck tumors, salivary gland tumors and thyroid tumors.


Fogarty Welcomes New Advisory Board Members
Fogarty International Center director Dr. Roger I. Glass (l) welcomes new advisory board members Dr. Maria Freire and Dr. Derek Yach.
Fogarty International Center director Dr. Roger I. Glass (l) welcomes new advisory board members Dr. Maria Freire and Dr. Derek Yach.

The Fogarty International Center recently welcomed several new advisory board members. Dr. Maria Freire and Dr. Derek Yach will provide guidance on funding awards and other activities. In addition, Dr. Kevin DeCock, new director of global health at CDC, has joined the board in an ex officio capacity.

Freire is president of the Albert and Mary Lasker Foundation. Prior to that appointment, she was CEO of the Global Alliance for TB Drug Development, which became the world leader in tuberculosis drug development under her leadership. She also directed NIHís Office of Technology Transfer from 1995 to 2001.

Yach is senior vice president of global health policy at PepsiCo Inc., where he heads engagement efforts with major international policy and scientific groups. Previously he was responsible for global health initiatives at the Rockefeller Foundation and headed the division of global health at Yale University.


back to top of page